Find stats on top websites
Axonics Therapy, the company's key product, is a sacral neuromodulation (SNM) system designed to treat overactive bladder (OAB), bowel incontinence, and urinary retention. A key feature is that it offers a long-term solution for bladder and bowel control issues. It's an alternative for patients who haven't found relief from prescription medications, lifestyle changes, or other treatments. The system is likely implantable, as it is referred to as sacral neuromodulation (SNM). Axonics highlights real stories and results from patients who have used the therapy, indicating a focus on demonstrable effectiveness. The company emphasizes safety and provides comprehensive information on potential risks associated with the therapy, indicating transparency and a commitment to patient well-being.
Axonics External Trial System
Axonics Sacral Neuromodulation System
Axonics MRI Safe System
Axonics offers a long-term solution to bladder and bowel dysfunction, providing patients with an effective therapy to improve their quality of life and regain control. Their therapy distinguishes itself by offering an alternative for those who have not found relief from traditional treatments, emphasizing both patient safety and demonstrable results.
Axonics positions itself as an innovator in bladder and bowel dysfunction solutions, offering Axonics Therapy as a long-term alternative to traditional treatments. Targeting individuals seeking improved quality of life and healthcare professionals, they emphasize patient education and support.
Medtronic
Boston Scientific
Olympus Corporation
Customer sentiment is likely positive due to the focus on improved quality of life and long-term solutions, but negative sentiment might arise from concerns about the high upfront costs. Axonics likely fosters trust by emphasizing safety and providing comprehensive information on potential risks.
Refine messaging to highlight the long-term benefits and improved quality of life offered by Axonics Therapy, particularly on social media platforms like Facebook and YouTube.
Axonics Therapy, the company's key product, is a sacral neuromodulation (SNM) system designed to treat overactive bladder (OAB), bowel incontinence, and urinary retention. A key feature is that it offers a long-term solution for bladder and bowel control issues. It's an alternative for patients who haven't found relief from prescription medications, lifestyle changes, or other treatments. The system is likely implantable, as it is referred to as sacral neuromodulation (SNM). Axonics highlights real stories and results from patients who have used the therapy, indicating a focus on demonstrable effectiveness. The company emphasizes safety and provides comprehensive information on potential risks associated with the therapy, indicating transparency and a commitment to patient well-being.
The Axonics® External Trial System is designed to allow patients to experience the benefits of Axonics therapy before committing to a full implant. It provides a temporary means of assessing symptom improvement related to bladder and bowel dysfunction. This trial period helps physicians and patients make informed decisions about whether to proceed with the Axonics sacral neuromodulation system.
Axonics® System is an FDA-approved, clinically proven Sacral Neuromodulation solution for the treatment of urinary and bowel dysfunction.
View sourceQuestions? We are here to help answer any questions you may have about the Axonics System and Therapy. CONTACT US · Corporate Healthcare Professionals Patients ...
View sourceJan 8, 2024 ... Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue. https://ir.axonics.com/news-releases. SOURCE Boston Scientific Corporation.
View sourceFeb 19, 2019 ... IRVINE, Calif. --(BUSINESS WIRE)--Feb. 19, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on ...
View sourceSign up now and unleash the power of AI for your business growth